Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv    crawled date : 2021 - 02 - 25    save search
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia
Published: 2021-02-25 (Crawled : 14:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
 | | O: -0.19% H: 0.76% C: -1.06%
treatment drug new drug application presbyopia
HUMIRA® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis
Published: 2021-02-25 (Crawled : 01:10) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
 | | O: -0.19% H: 0.76% C: -1.06%
fda fda approval approval ulcerative colitis
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.